US EditionPublished • loading... • Updated
Quotient Sciences records annual loss amid industry slowdown - East Midlands Business Link
Summary by East Midlands Business Link
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Quotient Sciences records annual loss amid industry slowdown - East Midlands Business Link
Drug development accelerator Quotient Sciences has reported an £8.8 million pre-tax loss for the year ending 31 December 2024, reversing its previous year’s £12.6 million profit. Revenue declined to £71.3 million from £74.2 million in 2023. The Ruddington-headquartered firm operates drug development, manufacturing, and clinical testing sites across the UK and US, including Reading, Edinburgh, […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
